We design and build the platforms, pipelines, and intelligence systems that healthcare and life sciences teams run their decisions on - from clinical data integration to decision analytics.
Built for pharma & biotech
HIPAA-aligned by design
HL7 / FHIR native
delveinsight / platform.log
27+
Therapeutic areas supported
FHIR
Interoperability standard
24/7
Platform monitoring
Decision
Deliverable-grade output
What we Build
Each engagement draws on the same core team - no handoffs between a "strategy" vendor and a "build" vendor.
Data
Pipelines that pull clinical, commercial, and real-world data into a single reliable source, cleaned and modeled for analysis.
AI-ML
Predictive engines from probability-of-success modeling to competitive forecasting designed for clear, evidence-based decision-making.
CI
Live dashboards that track pipeline, trials, and market movement in real time, replacing static quarterly reports.
Cloud
Scalable, monitored environments sized for how life sciences data actually behaves - bursty, sensitive, and audit-heavy.
Interop
Clean data exchange between EHRs, trial systems, and internal tools, so information moves without manual re-entry.
Security
Access controls, audit trails, and data governance built in from day one - not retrofitted before an audit.
Web
Built to bring your brand to life across marketing websites, service pages, and landing pages with a strong focus on design, usability, and seamless digital experiences.
Automation
Automated workflows that connect teams, systems, and data, reducing repetitive work, accelerating decisions, and keeping critical processes moving without manual handoffs.
Analytics
Interactive analytics that turn complex clinical, commercial, and operational data into clear insights, helping leadership identify trends, opportunities, and risks faster.
Digital Experience & Design
Digital platform, marketing websites, AI powered transformation, and apps designed and developed with a focus on usability, performance, and seamless digital experiences.
01 / Strategy
We help leadership teams adopt the CI, forecasting, and reporting frameworks that improve research efficiency, cross-team data sharing, and decision speed - without a multi-year enterprise IT roadmap.
02 / Data Integrity
From competitive intelligence intake to board reporting, we ensure data stays consistent, sourced, and reliable across every platform and team that touches it.
03 / R&D
We work alongside R&D and strategy teams to design intelligence workflows that shorten evaluation cycles, cut redundant analysis, and get competitive signal in front of the right people faster.
Built for Small, Cap Pharma
Enterprise IT vendors size everything for teams you don't have and budgets you haven't raised yet. Here's what's different when you work with us.
● NO in-house data team needed
No assumption of a dedicated data engineering or IT org on your side - we act as that function until you're ready to build one internally.
● Milestone-tied pricing
Phased scope tied to what's actually approved at each stage, instead of a fixed annual contract sized for a company three rounds ahead of you.
● Board-ready from sprint one
Every dashboard and model is CXO - and investor-presentation-ready from the first sprint - not a raw data export you have to translate yourself.
● One team, no handoffs
The same team that scopes the platform builds it - no translation loss between a consulting vendor and a separate dev shop.
● Built to scale with you
Architecture designed so a Series B, a pipeline expansion, or a new therapeutic area doesn't mean ripping out and rebuilding what we shipped at seed stage.
● Faster than enterprise vendors
A lean, senior team working directly with your decision-maker - not layers of account management standing between you and the people building your platform.
Deep, hands-on experience building intelligence software across oncology, rare disease, and broader pharma CI
Proven track record shipping production-grade platforms, not just static reports
Senior engineering team along with pharma consultants involved end-to-end
Built for both lean small-cap teams and enterprise IT functions alike
Trusted by competitive intelligence and IT teams at major pharma organizations
AI layered into your existing systems and workflows augmenting what already works instead of forcing a rip-and-replace
Why it matters: most healthcare IT vendors are built to sell into enterprise pharma procurement cycles. Small-cap and emerging biotech teams get the same price tag and timeline, sized for a company they aren`'t yet ; we scope the build for the company you are now.
By the Numbers
What 'comprehensive' actually looks like on the platforms we've shipped.
Tech Stack
15+
Core technologies powering every build - React, Node.js, Python, PostgreSQL, MongoDB, Docker, and more
DevOps
6+
DevOps tools and practices - CI/CD pipelines, containerization, and automated monitoring across AWS and Azure
Backend & Database
15+
External data sources, APIs, and integrations unified into one governed backend database
Frontend
20
Interactive components and modules across the front-end command-center UI
Proof, not Pitches
A mix of live intelligence platforms, forecasting engines, and CXO-facing web properties - scroll for the full set.
Scroll for more
FAQ
It covers everything from data pipeline and platform build to the strategy layer around it - competitive intelligence systems, forecasting engines, and the workflow design that gets that data in front of the right decision-makers.
Generic vendors build for enterprise procurement cycles and treat pharma as one industry among many. Everything here - the data model, the terminology, the review cadence - is built around how oncology, rare disease, and pharma CI teams actually work.
No. Most of the small-cap and emerging biotech teams we work with don't have a dedicated data function - we act as that function until you're ready to build one internally.
Yes - platforms are built HIPAA-aligned by design, with access controls, audit trails, and governance built in from day one rather than retrofitted before an audit.
Architecture is designed to extend to a new indication or funding stage without a rebuild - we've done this across oncology, rare disease, and broader pharma market intelligence.
Scope is phased and tied to what's actually approved at each funding milestone, rather than a fixed annual contract sized for a company several rounds ahead of you.
Static quarterly reports miss pipeline shifts, trial readouts, and competitor moves in real time - decisions end up made on data that's already stale by the time it reaches the board.
Discovery and scoping run 1-2 weeks, architecture 2-4 weeks, and CXO-facing views are usable from the first build sprint after that - see the full process above.
Get Started
A short discovery call, no slide deck required. We'll bring questions about your current systems, not a pitch.